LEXINGTON, Mass.--(BUSINESS WIRE)-- Agenus Inc. (“Agenus” or the “Company”) (Nasdaq: AGEN), an immuno-oncology company advancing innovative cancer therapies, today reported financial and operational ...

Agenus Reports Q4 and Year-End 2024 Results; Strategic Operational Improvements and Significant Cost Reductions Enhance Sustainability of Promising BOT/BAL Program Agenus Inc. (“Agenus” or the ...

TYSONS CORNER, Va.--(BUSINESS WIRE)-- Strategy™ (Nasdaq: MSTR; STRK; STRF; STRD; STRC) today announced that it has entered into a sales agreement pursuant to which Strategy may issue and sell shares ...

New rapid-response advisory service bridges the critical gap between enterprise IT strategy and the kinetic reality of autonomous systems. Executives need a way to see around corners without ...